Skip to main content
SpringerLink
Log in
Book cover

Gerodontology Essentials for Health Care Professionals pp 67–86Cite as

Medications and Oral Health: Points to Consider in Older People

  • Chapter
  • First Online:

  • 542 Accesses

Part of the book series: Practical Issues in Geriatrics ((PIG))

Abstract

This chapter describes the increase of chronic illness, multimorbidity, care dependency, and related polypharmacy as a consequence of ageing. Moreover, a focus has been put on drug-related oral health problems since clear associations have been found between the medication intake and the oral status of older people. Prescribing physicians must be aware of the potential oral complications caused by medications in order to be able to develop an appropriate and tailored treatment plan that also considers oral health-related complications. Approaches to identify potential drug-related problems and to optimize medication use comprise medication reconciliation followed by medication review and criteria to assess quality of prescribing, preferably incorporated in computer-based prescribing systems and as a part of comprehensive geriatric assessment (CGA) and management.

Taking into consideration the differences in life expectancy, and in order to provide an integrated plan for treatment, rehabilitation, support and long-term care, CGA and assessment of multimorbidity are assumed to distinguish between three groups of older patients, i.e. fit, vulnerable, and frail.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Stewart R, Cooper J. Polypharmacy in the aged. Practical solutions. Drugs Aging. 1994;4:449–61.

    Article  CAS  PubMed  Google Scholar 

  2. van den Bemt P, Egberts A, Lenderink A, Verzijl J, Simons K, van der Pol W, et al. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci. 2000;22:62–6.

    Article  PubMed  Google Scholar 

  3. Hajjar E, Hanlon J, Artz M, Lindblad C, Pieper C, Sloane R, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother. 2003;1:82–9.

    Article  PubMed  Google Scholar 

  4. Field T, Gurwitz J, Avorn J, McCormick D, Jain S, Eckler M, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001;161:1629–34.

    Article  CAS  PubMed  Google Scholar 

  5. Field T, Gurwitz J, Harrold L, Rothschild J, Debellis K, Seger A, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004;52:1349–54.

    Article  PubMed  Google Scholar 

  6. Lund B, Carnahan R, Egge J, Chrischilles E, Kaboli P. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother. 2010;44:957–63.

    Article  PubMed  Google Scholar 

  7. Steinman M, Landefeld C, Rosenthal G, Berthenthal D, Sen S, Kaboli P. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:1516–23.

    Article  PubMed  Google Scholar 

  8. Page R, Linnebur S, Bryant L, Ruscin M. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hajjar E, Cafiero A, Hanlon J. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:314–6.

    Article  Google Scholar 

  10. Goldberg R, Mabee J, Chan L, Wong S. Drug-drug and drug disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14:447–50.

    Article  CAS  PubMed  Google Scholar 

  11. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150:841–5.

    Article  CAS  PubMed  Google Scholar 

  12. Petrovic M, Gnjidic D, Tommelein E, Boussery K. Pharmacotherapy. In: Roller-Wirnsberger R, Singler K, Polidori MC, editors. Learning geriatric medicine: a study guide for medical students. Cham: Springer International Publishing AG; 2018. p. 219–35.

    Chapter  Google Scholar 

  13. Laroche ML, Charmes JP, Marcheix A, Bouthier F, Merle L. Estimation of glomerular filtration rate in the elderly: Cockcroft-Gault formula versus modification of diet in renal disease formula. Pharmacotherapy. 2006;26:1041–6.

    Article  PubMed  Google Scholar 

  14. Page R, Linnebur S, Bryant L, et al. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kinirons MT, Crome P. Clinical pharmacokinetic considerations in the elderly: an update. Clin Pharmacokinet. 1997;33:302–12.

    Article  CAS  PubMed  Google Scholar 

  16. Mayersohn M. Pharmacokinetics in the elderly. Environ Health Perspect. 1994;102(Suppl. 11):119–24.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Klotz U, Avant G, Hoyumpa A, Schenker S, Wilkinson G. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest. 1975;55:347–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Swift C. Pharmacodynamics: changes in homeostatic mechanisms, receptor and target organ sensitivity in the elderly. Br Med Bull. 1990;40:36–52.

    Article  Google Scholar 

  19. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991;114:956–66.

    Article  CAS  PubMed  Google Scholar 

  20. Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001;51:615–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Lindley C, Tully M, Paramsothy V, Tallis R. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing. 1992;21:294–300.

    Article  CAS  PubMed  Google Scholar 

  22. Janssens B, Petrovic M, Jacquet W, Schols J, Vanobbergen J, De Visschere L. Medication use and its potential impact on the oral health status of nursing home residents in Flanders (Belgium). J Am Med Dir Assoc. 2017;18:809.e1–8.

    Article  Google Scholar 

  23. Singh M, Papas A. Oral implications of polypharmacy in the elderly. Dent Clin N Am. 2014;58:783–96.

    Article  PubMed  Google Scholar 

  24. Xu F, Laguna L, Anwesha S. Aging-related changes in quantity and quality of saliva: where do we stand in our understanding? J Texture Stud. 2019;50:27–35.

    Article  PubMed  Google Scholar 

  25. Das P, Challacombe S. Dry mouth and clinical oral dryness scoring systems. Prim Dent J. 2016;5:77–9.

    PubMed  Google Scholar 

  26. Affo R, Foley N, Garrick R, Siqueira W, Martin R. Meta-analysis of salivary flow rates in young and older adults. J Am Geriatr Soc. 2015;63:2142–51.

    Article  Google Scholar 

  27. Navazesh M, Christensen C, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res. 1992;71:1363–9.

    Article  CAS  PubMed  Google Scholar 

  28. Amerongen AV, Veerman EC. Saliva—the defender of the oral cavity. Oral Dis. 2002;8:12–22.

    Article  PubMed  Google Scholar 

  29. Vissink A, Spijkervet FK, Van Nieuw Amerongen A. Aging and saliva: a review of the literature. Spec Care Dentist. 1996;16:95–103.

    Article  CAS  PubMed  Google Scholar 

  30. Smidt D, Torpet L, Nauntofte B, Heegaard K, Pedersen A. Associations between oral and ocular dryness, labial and whole salivary flow rates, systemic diseases and medications in a sample of older people. Community Dent Oral Epidemiol. 2011;39:276–88.

    Article  CAS  PubMed  Google Scholar 

  31. Smidt D, Torpet L, Nauntofte B, Heegaard K, Pedersen A. Associations between labial and whole salivary flow rates, systemic diseases and medications in a sample of older people. Community Dent Oral Epidemiol. 2010;38:422–35.

    Article  PubMed  Google Scholar 

  32. Turner M, Ship J. Dry mouth and its effects on the oral health of elderly people. J Am Dent Assoc. 2007;138(Suppl):15S–20S.

    Article  PubMed  Google Scholar 

  33. Balakumar P, Kavitha M, Nanditha S. Cardiovascular drugs-induced Oral toxicities: a murky area to be revisited and illuminated. Pharmacol Res. 2015;102:81–9.

    Article  CAS  PubMed  Google Scholar 

  34. Yuan A, Woo S. Adverse drug events in the oral cavity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:35–47.

    Article  PubMed  Google Scholar 

  35. Boulinguez S, Reix S, Bedane C, Debrock C, Bouyssou-Gauthier ML, Sparsa A, Le Brun V, De Vencay P, Bernard P, Bonnetblanc J. Role of drug exposure in aphthous ulcers: a case-control study. Br J Dermatol. 2000;143:1261–5.

    Article  CAS  PubMed  Google Scholar 

  36. Siegel M, Balciunas B. Medication can induce severe ulcerations. J Am Dent Assoc. 1991;122:75–7.

    Article  CAS  PubMed  Google Scholar 

  37. Healy C, Thornhill M. An association between recurrent oro-genital ulceration and non-steroidal anti-inflammatory drugs. J Oral Pathol Med. 1995;24:46–8.

    Article  CAS  PubMed  Google Scholar 

  38. Goffin E, Pochet J, Lejuste P, De Plaen J. Aphtous ulcers of the mouth associated with losartan. Clin Nephrol. 1998;50:197.

    CAS  PubMed  Google Scholar 

  39. Susser W, Whitaker-Worth D, Grant-Kels J. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol. 1999;40:367–98.

    Article  CAS  PubMed  Google Scholar 

  40. Logan R, Stringer A, Bowen J, Gibson R, Sonis S, Keefe D. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother Pharmacol. 2009;63:239–51.

    Article  CAS  PubMed  Google Scholar 

  41. Sonis S. Regimen-related gastrointestinal toxicities in cancer patients. Curr Opin Support Palliat Care. 2010;4:26–30.

    Article  PubMed  Google Scholar 

  42. Ciancio S. Medications’ impact on oral health. J Am Dent Assoc. 2004;135:1440–8.

    Article  PubMed  Google Scholar 

  43. Edwards PC, Kelsch R. Oral lichen planus: clinical presentation and management. J Can Dent Assoc. 2002;68:494–9.

    PubMed  Google Scholar 

  44. Lavanya N, Jayanthi P, Rao U, Ranganathan K. Oral lichen planus: an update on pathogenesis and treatment. J Oral Maxillofac Pathol. 2011;15:127–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Coulter D. Eye pain with nifedipine and disturbance of taste with captopril: a mutually controlled study showing a method of postmarketing surveillance. Br Med J (Clin Res Ed). 1988;296:1086–8.

    Article  CAS  Google Scholar 

  46. Boyd I. Captopril-induced taste disturbance. Lancet. 1993;342:304.

    Article  CAS  PubMed  Google Scholar 

  47. Heeringa M, van Puijenbroek E. Reversible dysgeusia attributed to losartan. Ann Intern Med. 1998;129:72.

    Article  CAS  PubMed  Google Scholar 

  48. Tsuruoka S, Wakaumi M, Ioka T, Yamamoto H, Ando H, Sugimoto K, Fujimura A. Angiotensin II receptor blocker-induces blunted taste sensitivity: comparison of candesartan and valsartan. Br J Clin Pharmacol. 2005;60:204–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Sadasivam B, Jhaj R. Dysgeusia with amlodipine—a case report. Br J Clin Pharmacol. 2007;63:253.

    Article  PubMed  Google Scholar 

  50. Ackerman B, Kasbekar N. Disturbances of taste and smell induced by drugs. Pharmacotherapy. 1997;17:482–96.

    CAS  PubMed  Google Scholar 

  51. Maier C. Life-threatening postoperative angioedema following treatment with an angiotensin converting enzyme inhibitor. Anaesthesist. 1995;44:875–9.

    Article  CAS  PubMed  Google Scholar 

  52. Hall R. Angioedema and ACE inhibitors. Periodont Insights. 1998;5:6–7.

    Google Scholar 

  53. Israili Z, Hall W. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med. 1992;117:234–42.

    Article  CAS  PubMed  Google Scholar 

  54. Chin H, Buchan D. Severe angioedema after long-term use of an angiotensin-converting enzyme inhibitor. Ann Intern Med. 1990;112:312–3.

    Article  CAS  PubMed  Google Scholar 

  55. Campbell D, Krum H, Esler M. Losartan increases bradykinin levels in hypertensive humans. Circulation. 2005;111:315–20.

    Article  CAS  PubMed  Google Scholar 

  56. Lo K. Angioedema associated with candesartan. Pharmacotherapy. 2002;22:1176–9.

    Article  PubMed  Google Scholar 

  57. Irons B, Kumar A. Valsartan-induced angioedema. Ann Pharmacother. 2003;37:1024–7.

    Article  PubMed  Google Scholar 

  58. Nykamp D, Winter E. Olmesartan medoxomil-induced angioedema. Ann Pharmacother. 2007;41:518–20.

    Article  CAS  PubMed  Google Scholar 

  59. ONTARGET Investigators, Yusuf S, Teo K, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547–59.

    Article  Google Scholar 

  60. Jagadeesh G, Balakumar P, Stockbridge N. How well do aliskiren’s purported mechanisms track its effects on cardiovascular and renal disorders? Cell Signal. 2012;24:1583–91.

    Article  CAS  PubMed  Google Scholar 

  61. Southward J, Irvine E, Rabinovich M. Probable amlodipine-induced angioedema. Ann Pharmacother. 2009;43:772–6.

    Article  CAS  PubMed  Google Scholar 

  62. Pierce W, Hederman A, Gordon C, Ostrenga A, Herrington B. Angioedema associated with dihydropyridine calcium-channel blockers in a child with Burkitt lymphoma. Am J Health Syst Pharm. 2011;68:402–6.

    Article  CAS  PubMed  Google Scholar 

  63. Ruscin J, Page R 2nd, Scott J. Hydrochlorothiazide-induced angioedema in a patient allergic to sulphonamide antibiotics: evidence from a case report and a review of the literature. Am J Geriatr Pharmacother. 2006;4:325–9.

    Article  PubMed  Google Scholar 

  64. Nisly S, Kara A, Knight T. Simvastatin: a risk factor for angioedema? J Pharm Technol. 2013;29:149–52.

    Article  Google Scholar 

  65. Hampson J, Smith D, Cowell R, Baker A. Hypotension and eosinophilia with atorvastatin. Pharm World Sci. 2005;27:279–80.

    Article  CAS  PubMed  Google Scholar 

  66. Rees S, Gibson J. Angioedema and swellings of the orofacial region. Oral Dis. 1997;3:39–42.

    Article  CAS  PubMed  Google Scholar 

  67. Dongari-Bagtzoglou A, Research, Science and Therapy Committee, American Academy of Periodontology. Drug-associated gingival enlargement. J Periodontol. 2004;75:1424–31.

    Article  PubMed  Google Scholar 

  68. Sam G, Sebastian S. Nonsurgical management of nifedipine induced gingival overgrowth. Case Rep Dent. 2014;2014:741402.

    PubMed  PubMed Central  Google Scholar 

  69. Bhatia V, Mittal A, Parida A, Talwar R, Kaul U. Amlodipine induced gingival hyperplasia: a rare entity. Int J Cardiol. 2007;122:e23–4.

    Article  PubMed  Google Scholar 

  70. Young P, Turiansky G, Sau P, Liebman M, Benson P. Felodipine-induced gingival hyperplasia. Cutis. 1998;62:41–3.

    CAS  PubMed  Google Scholar 

  71. Maguin B, Yachouh J, Goudot P. Nicardipine-induced gingival hyperplasia: case report. Rev Stomatol Chir Maxillofac. 2004;105:219–21.

    Article  CAS  PubMed  Google Scholar 

  72. Brown R, Sein P, Corio R, Bottomley W. Nitrendipine-induced gingival hyperplasia. First case report. Oral Surg Oral Med Oral Pathol. 1990;70:593–6.

    Article  CAS  PubMed  Google Scholar 

  73. Hall W. Dilantin hyperplasia: a preventable lesion? Compend Suppl. 1990;14:S502–5.

    Google Scholar 

  74. Ciancio S, Yaffe S, Catz C. Gingival hyperplasia and diphenylhydantoin. J Periodontol. 1972;43:411–4.

    Article  CAS  PubMed  Google Scholar 

  75. Nakade O, Baylink D, Lau K. Phenytoin at micromolar concentrations is an osteogenic agent for human-mandible-derived bone cells in vitro. J Dent Res. 1995;74:331–7.

    Article  CAS  PubMed  Google Scholar 

  76. Ellis J, Seymour R, Steele J, Robertson P, Butler T, Thomason J. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol. 1999;70:63–7.

    Article  CAS  PubMed  Google Scholar 

  77. Nishikawa S, Tada H, Hamasaki A, Kasahara S, Kido J, Nagata T, Ishida H, Wakano Y. Nifedipine-induced gingival hyperplasia: a clinical and in vitro study. J Periodontol. 1991;62:30–5.

    Article  CAS  PubMed  Google Scholar 

  78. Seymour R, Smith D. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol. 1991;18:107–10.

    Article  CAS  PubMed  Google Scholar 

  79. Ortín M, Olalla JI, Muruzábal MJ, Peralta FG, Gutiérrez MA. Miconazole oral gel enhances acenocoumarol anticoagulant activity: a report of three cases. Ann Pharmacother. 1999;33:175–7.

    Article  PubMed  Google Scholar 

  80. Sindet-Pedersen S, Ramström G, Bernvil S, Blombäck M. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med. 1989;320:840–3.

    Article  CAS  PubMed  Google Scholar 

  81. Farhat G, Yamout B, Mikati M, Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology. 2002;58:1348–53.

    Article  CAS  PubMed  Google Scholar 

  82. Salvatore R, Dodson T, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg. 2014;72:1938–56.

    Article  Google Scholar 

  83. Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F. Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol. 2012;42:922–32.

    Article  Google Scholar 

  84. Diniz-Freitas M, Limeres J. Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review. Med Oral Patol Oral Cir Bucal. 2016;21:e250–9.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Sreeja C, Ramakrishnan K, Vijayalakshmi D, Devi M, Aesha I, Vijayabanu B. Oral pigmentation: a review. J Pharm Bioallied Sci. 2015;7(Suppl 2):S403–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Anil Kumar N, Divya P. Adverse drug effects in mouth. Int J Med Appl Sci. 2015;4:82–91.

    Google Scholar 

  87. Onder G, van der Cammen T, Petrovic M, Somers A, Rajkumar C. Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing. 2013;42:284–91.

    Article  PubMed  Google Scholar 

  88. Agency for Healthcare Research and Quality U.S. Department of Health and Human Services; 2012. https://www.ahrq.gov/sites/default/files/publications/files/match.pdf. Accessed 8 Dec 2019.

  89. NHS Cumbria Medicines Management Team. 2013. http://www.cumbria.nhs.uk/ProfessionalZone/MedicinesManagement/Guidelines/MedicationReview-PracticeGuide2011.pdf. Accessed 8 Dec 2019.

  90. Kaufmann C, Tremp R, Hersberger K, Lampert M. Inappropriate prescribing: a systematic overview of published assessment tools. Eur J Clin Pharmacol. 2014;70:1–11.

    Article  PubMed  Google Scholar 

  91. Tommelein E, Petrovic M, Somers A, Mehuys E, van der Cammen T, Boussery K. Older patients’ prescriptions screening in the community pharmacy: development of the Ghent older People’s prescriptions community pharmacy screening (GheOP3S) tool. J Public Health (Oxf). 2016;38:e158–70.

    Article  Google Scholar 

  92. O’Mahony D, O’Sullivan D, Byrne S, O’Connor M, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.

    Article  PubMed  Google Scholar 

  93. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63:2227–46.

    Article  Google Scholar 

  94. Renom Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71:861–75.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane K, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173–84.

    Article  PubMed  Google Scholar 

  96. Beers M, Ouslander J, Rollingher I, Reuben D, Brooks J, Beck J. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825–32.

    Article  CAS  PubMed  Google Scholar 

  97. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616–31.

    Article  Google Scholar 

  98. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.

    Article  CAS  PubMed  Google Scholar 

  99. Hanlon J, Schmader K, Samsa G, Weinberger M, Uttech K, Lewis I, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.

    Article  CAS  PubMed  Google Scholar 

  100. Somers A, Mallet L, van der Cammen T, Robays H, Petrovic M. Applicability of an adapted medication appropriateness index for detection of drug-related problems in geriatric inpatients. Am J Geriatr Pharmacother. 2012;10:101–9.

    Article  PubMed  Google Scholar 

  101. Vander Walde N, Jagsi R, Dotan E, Baumgartner J, Browner I, Burhenn P, et al. NCCN guidelines insights: older adult oncology, version 2.2013. J Natl Cancer Netw. 2016;14:1357–70.

    Article  Google Scholar 

  102. Stauder R. The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients. Ann Hematol. 2012;91:1333–43.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist. 2000;5:224–37.

    Article  CAS  PubMed  Google Scholar 

  104. Geriatric Medicine Research, Dalhousie University, Halifax. https://www.dal.ca/sites/gmr/our-tools/clinical-frailty-scale.html. Accessed 8 Dec 2019.

  105. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J. 2005;173:489–95.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Paediatrics, Section of Geriatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium

    Mirko Petrovic

  2. Department of Oral Health Sciences, Special Needs in Oral Health, Gerodontology, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium

    Barbara Janssens

Authors
  1. Mirko Petrovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Janssens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mirko Petrovic .

Editor information

Editors and Affiliations

  1. School of Dentistry, National and Kapodistrian University of Athens, Athens, Greece

    Anastassia Kossioni

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Petrovic, M., Janssens, B. (2020). Medications and Oral Health: Points to Consider in Older People. In: Kossioni, A. (eds) Gerodontology Essentials for Health Care Professionals. Practical Issues in Geriatrics. Springer, Cham. https://doi.org/10.1007/978-3-030-41468-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-41468-9_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-41467-2

  • Online ISBN: 978-3-030-41468-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation